The article Cybin Reports Q3 Financial Results and Business Highlights was originally published on Microdose.
Cybin has released its Q3 financial results and business highlights. Besides a solid cash position and developmental progress, the biggest news is that Cybin will provide CYB003 Phase 1/2a interim study readout and update on its CYB004 program at its upcoming R&D Day on February 28, 2023. Analyst Elemer Piros at EF Hutton has reiterated […]
The article Valentine’s Day Perspective: Sex and Psychedelics was originally published on Microdose.
To help celebrate Valentine’s Day, we’re re-posting this piece on Sex & Psychedelics from Nicolle Hodges. For more like this, check out: Sex & Psychedelics Series: Owning Desire and Sex & Psychedelics: Altering Our States of Consciousness Flee Not the Body in Pursuit of Spirit “Who is here because they want to know the best […]
The article News You Might Have Missed: Feb 13th, 2023 was originally published on Microdose.
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. It was a busy week with lots of news, have a look and see you next week for another update. Awakn Life Sciences Granted Fast-Track Designation from UK for Ketamine […]
The article Virginia & Hawaii Move Psychedelic Decrim Bills Forward was originally published on Microdose.
For more decrim and legalization news, check out 2023 Starts With Psychedelic Decrim Measures In Several States and Australia Legalizes Psychedelics: Are the US and Canada Next? Virginia psychedelic bill passes the Senate The Virginia state senate has passed a bill that would reclassify psilocybin from a Schedule I to Schedule III. The bill […]
